174 related articles for article (PubMed ID: 29913906)
1. Using fMRI to evaluate the effects of milnacipran on central pain processing in patients with fibromyalgia.
Petzke F; Jensen KB; Kosek E; Choy E; Carville S; Fransson P; Williams SCR; Marcus H; Mainguy Y; Ingvar M; Gracely RH
Scand J Pain; 2013 Apr; 4(2):65-74. PubMed ID: 29913906
[TBL] [Abstract][Full Text] [Related]
2. Segregating the cerebral mechanisms of antidepressants and placebo in fibromyalgia.
Jensen KB; Petzke F; Carville S; Choy E; Fransson P; Gracely RH; Vitton O; Marcus H; Williams SC; Ingvar M; Kosek E
J Pain; 2014 Dec; 15(12):1328-37. PubMed ID: 25283470
[TBL] [Abstract][Full Text] [Related]
3. Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial.
Clauw DJ; Mease P; Palmer RH; Gendreau RM; Wang Y
Clin Ther; 2008 Nov; 30(11):1988-2004. PubMed ID: 19108787
[TBL] [Abstract][Full Text] [Related]
4. Effect of Milnacipran Treatment on Ventricular Lactate in Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Trial.
Natelson BH; Vu D; Mao X; Weiduschat N; Togo F; Lange G; Blate M; Kang G; Coplan JD; Shungu DC
J Pain; 2015 Nov; 16(11):1211-9. PubMed ID: 26335989
[TBL] [Abstract][Full Text] [Related]
5. Resting state connectivity correlates with drug and placebo response in fibromyalgia patients.
Schmidt-Wilcke T; Ichesco E; Hampson JP; Kairys A; Peltier S; Harte S; Clauw DJ; Harris RE
Neuroimage Clin; 2014; 6():252-61. PubMed ID: 25379438
[TBL] [Abstract][Full Text] [Related]
6. Effects of milnacipran on clinical pain and hyperalgesia of patients with fibromyalgia: results of a 6-week randomized controlled trial.
Staud R; Lucas YE; Price DD; Robinson ME
J Pain; 2015 Aug; 16(8):750-9. PubMed ID: 25998206
[TBL] [Abstract][Full Text] [Related]
7. The efficacy and safety of milnacipran for treatment of fibromyalgia. a randomized, double-blind, placebo-controlled trial.
Mease PJ; Clauw DJ; Gendreau RM; Rao SG; Kranzler J; Chen W; Palmer RH
J Rheumatol; 2009 Feb; 36(2):398-409. PubMed ID: 19132781
[TBL] [Abstract][Full Text] [Related]
8. Preliminary experience using milnacipran in patients with juvenile fibromyalgia: lessons from a clinical trial program.
Arnold LM; Bateman L; Palmer RH; Lin Y
Pediatr Rheumatol Online J; 2015 Jun; 13():27. PubMed ID: 26112278
[TBL] [Abstract][Full Text] [Related]
9. A pooled analysis of two randomized, double-blind, placebo-controlled trials of milnacipran monotherapy in the treatment of fibromyalgia.
Geisser ME; Palmer RH; Gendreau RM; Wang Y; Clauw DJ
Pain Pract; 2011; 11(2):120-31. PubMed ID: 20642487
[TBL] [Abstract][Full Text] [Related]
10. A double-blind placebo-controlled trial of milnacipran in the treatment of fibromyalgia.
Vitton O; Gendreau M; Gendreau J; Kranzler J; Rao SG
Hum Psychopharmacol; 2004 Oct; 19 Suppl 1():S27-35. PubMed ID: 15378666
[TBL] [Abstract][Full Text] [Related]
11. Role and rationale for the use of milnacipran in the management of fibromyalgia.
Kranzler JD; Gendreau RM
Neuropsychiatr Dis Treat; 2010 May; 6():197-208. PubMed ID: 20520784
[TBL] [Abstract][Full Text] [Related]
12. A European multicenter randomized double-blind placebo-controlled monotherapy clinical trial of milnacipran in treatment of fibromyalgia.
Branco JC; Zachrisson O; Perrot S; Mainguy Y;
J Rheumatol; 2010 Apr; 37(4):851-9. PubMed ID: 20156949
[TBL] [Abstract][Full Text] [Related]
13. Prediction of Differential Pharmacologic Response in Chronic Pain Using Functional Neuroimaging Biomarkers and a Support Vector Machine Algorithm: An Exploratory Study.
Ichesco E; Peltier SJ; Mawla I; Harper DE; Pauer L; Harte SE; Clauw DJ; Harris RE
Arthritis Rheumatol; 2021 Nov; 73(11):2127-2137. PubMed ID: 33982890
[TBL] [Abstract][Full Text] [Related]
14. Longterm therapeutic response to milnacipran treatment for fibromyalgia. A European 1-year extension study following a 3-month study.
Branco JC; Cherin P; Montagne A; Bouroubi A;
J Rheumatol; 2011 Jul; 38(7):1403-12. PubMed ID: 21459941
[TBL] [Abstract][Full Text] [Related]
15. Short-term (2-week) effects of discontinuing milnacipran in patients with fibromyalgia.
Saxe PA; Arnold LM; Palmer RH; Gendreau RM; Chen W
Curr Med Res Opin; 2012 May; 28(5):815-21. PubMed ID: 22429066
[TBL] [Abstract][Full Text] [Related]
16. Durability of therapeutic response to milnacipran treatment for fibromyalgia. Results of a randomized, double-blind, monotherapy 6-month extension study.
Goldenberg DL; Clauw DJ; Palmer RH; Mease P; Chen W; Gendreau RM
Pain Med; 2010 Feb; 11(2):180-94. PubMed ID: 20002596
[TBL] [Abstract][Full Text] [Related]
17. Dual reuptake inhibitor milnacipran and spinal pain pathways in fibromyalgia patients: a randomized, double-blind, placebo-controlled trial.
Matthey A; Cedraschi C; Piguet V; Besson M; Chabert J; Daali Y; Courvoisier D; Montagne A; Dayer P; Desmeules JA
Pain Physician; 2013; 16(5):E553-62. PubMed ID: 24077206
[TBL] [Abstract][Full Text] [Related]
18. Milnacipran: a selective serotonin and norepinephrine dual reuptake inhibitor for the management of fibromyalgia.
Palmer RH; Periclou A; Banerjee P
Ther Adv Musculoskelet Dis; 2010 Aug; 2(4):201-20. PubMed ID: 22870448
[TBL] [Abstract][Full Text] [Related]
19. Functional magnetic resonance imagery (fMRI) in fibromyalgia and the response to milnacipran.
Mainguy Y
Hum Psychopharmacol; 2009 Jun; 24 Suppl 1():S19-23. PubMed ID: 19479905
[TBL] [Abstract][Full Text] [Related]
20. Continuing efficacy of milnacipran following long-term treatment in fibromyalgia: a randomized trial.
Clauw DJ; Mease PJ; Palmer RH; Trugman JM; Wang Y
Arthritis Res Ther; 2013 Aug; 15(4):R88. PubMed ID: 23953493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]